| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.3 | 4e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |